Latest News

Backing Secured to Prepare First Trial of Implanted Electric Field Therapy
May 7

Awarded £1.26M in funding through Innovate UK, as part of the Biomedical Catalyst. Supports regulatory testing ahead of a first-in-human…

Read More
Carl Daintree Joins QV Bioelectronics as COO
March 12

Welcoming Carl to QV Bioelectronics! We’re excited to welcome Carl Daintree to the QV Bioelectronics team as the new COO!…

Read More
QV Bioelectronics Delivers Breakthrough Pre-Clinical Safety and Efficacy Results for Electric Field Therapy in the treatment of Glioblastoma
September 9

Safety of QV’s novel stimulation regimes demonstrated in large animal studies for up to three months of implantation. Pre-clinical data…

Read More
QV Bioelectronics secures £343,000 from Innovate UK’s Cancer Therapeutics programme to develop a new treatment for childhood brain tumours.
August 30

Press Release The project will adapt QV Bioelectronics’ existing electric field therapy (EFT) technology to develop the world’s first fully…

Read More
QV Bioelectronics and Incubate Bio announce successful outcome of strategic collaboration to accelerate new treatment option for Glioblastoma
October 24

Collaboration delivered vital insights to advance revolutionary treatment modality – GRACE ALaSCA platform able to decipher experimental data from complex…

Read More
Michaela Joins QV as Summer Intern
July 10

Exciting News: Welcome Michaela Baek, Our New Summer Intern at QV Bioelectronics! ? Michaela, an aspiring biologist, is eager to…

Read More